Myocardial infarction in a low risk patient with hereditary hemorrhagic telangiectasia.
We describe the case of a 57 year-old woman with NSTE ACS, a history of recurrent and prolonged epistaxis, and low prior cardiovascular risk. Additional findings revealed anemia and an aneurysm in her central nervous system. During her hospital stay, hereditary hemorrhagic telangiectasia (HHT) was diagnosed. After application of two antiplatelet drugs, the patient was scheduled for coronarography, followed by coronary artery bypass grafting. During her hospital stay, only a minor episode of epistaxis was observed. We conclude that anemization due to HTT may significantly accelerate the progress of ischemic heart disease, resulting in acute coronary syndrome. Moreover, coronarography preceded by routine application of two antiplatelet drugs seems not to increase the risk of hemorrhage in HHT patients complicated with myocardial infarction.
Janion
Marianna
M
Swietokrzyskie Cardiology Centre, Regional District Hospital Department of Cardiology, Kielce, Poland.
Brzyzkiewicz
Halina
H
Siuda
Marcin
M
Domagała
Szymon
S
Karliński
Michał
M
D054058:Acute Coronary Syndrome / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000601:surgery*; D000740:Anemia / Q000097:blood / Q000209:etiology; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects; D004844:Epistaxis / Q000209:etiology; D005260:Female; D006801:Humans; D018810:Magnetic Resonance Angiography; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors